GCP
GRTS

GSA Capital Partners’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

GSA Capital Partners’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-136,113
Closed -$265K – 2012
2023
Q2 		$265K Buy
+136,113
New +$319K 0.03% 1121
2022
Q2 		– Sell
-30,939
Closed -$127K – 1888
2022
Q1 		$127K Buy
+30,939
New +$164K 0.02% 1260
2021
Q4 		– Sell
-40,303
Closed -$435K – 1875
2021
Q3 		$435K Buy
+40,303
New +$367K 0.04% 781

Other funds holding GRTS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GSA Capital Partners's GRTS Position: Q3 2023 in Review

GSA Capital Partners sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q3 2023, closing a stake of 136,113 shares — an estimated $265K sold.

GSA Capital Partners first reported a position in GRTS in Q3 2021 and held it in 3 quarters. The position peaked at $435K in Q3 2021. 89 funds tracked by Wall St. Rank hold GRTS as of Q3 2023.

  • GSA Capital Partners reported no remaining Gritstone bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • GSA Capital Partners sold 136,113 Gritstone bio, Inc. Common Stock shares in Q3 2023, an estimated $265K.
  • GSA Capital Partners first reported a position in Gritstone bio, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • GSA Capital Partners's Gritstone bio, Inc. Common Stock position peaked at $435K in Q3 2021.
  • 89 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2023.

Based on GSA Capital Partners's 13F filing for Q3 2023, filed 15 Nov 2023.